PEPTIDE DOSE: Select dose
DRAW SYRINGE TO: Select values
YOUR VIAL CONTAINS: Select values
CONCENTRATION: Select values
Tirzepatide is an innovative dual-action peptide that targets both Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. This unique mechanism has made it a significant focus of metabolic research, particularly in studies involving blood glucose regulation, weight management, and overall metabolic health.
By mimicking the body’s natural incretin hormones, Tirzepatide helps support insulin secretion in response to elevated blood glucose levels while simultaneously reducing appetite and slowing gastric emptying. These combined actions contribute to improved metabolic efficiency and enhanced glycemic control.
Apply once, get reviewed by our team, and access provider-only pricing across peptides, exosomes, and cellular products.
PRODUCT USAGE: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product is intended strictly for laboratory research and qualifies under appropriate regulatory frameworks for research-only use. It is not intended to diagnose, treat, cure, or prevent any disease or condition. This product should only be handled by licensed, qualified professionals. It is not intended for use by the general public. Bodily introduction of any kind into humans or animals is strictly forbidden by law.